Your browser doesn't support javascript.
loading
CBP Modulates Sensitivity to Dasatinib in Pre-BCR+ Acute Lymphoblastic Leukemia.
Duque-Afonso, Jesús; Lin, Chiou-Hong; Han, Kyuho; Morgens, David W; Jeng, Edwin E; Weng, Ziming; Jeong, Johan; Wong, Stephen Hon Kit; Zhu, Li; Wei, Michael C; Chae, Hee-Don; Schrappe, Martin; Cario, Gunnar; Duyster, Justus; Xiao, Xiangshu; Sakamoto, Kathleen M; Bassik, Michael C; Cleary, Michael L.
  • Duque-Afonso J; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Lin CH; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
  • Han K; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Morgens DW; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Jeng EE; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Weng Z; Department of Genetics, Stanford University School of Medicine, Stanford, California.
  • Jeong J; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Wong SHK; Stanford Center for Genomics and Personalized Medicine, Stanford, California.
  • Zhu L; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Wei MC; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Chae HD; Department of Pathology, Stanford University School of Medicine, Stanford, California.
  • Schrappe M; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Cario G; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
  • Duyster J; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Xiao X; Department of Pediatrics, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Sakamoto KM; Department of Hematology and Oncology, University Medical Center Freiburg, Freiburg, Germany.
  • Bassik MC; Department of Physiology and Pharmacology, Oregon Health and Science University, Portland, Oregon.
  • Cleary ML; Department of Pediatrics, Stanford University School of Medicine, Stanford, California.
Cancer Res ; 78(22): 6497-6508, 2018 11 15.
Article en En | MEDLINE | ID: mdl-30262461
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Proteína de Unión a CREB / Leucemia-Linfoma Linfoblástico de Células Precursoras / Dasatinib / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Proteína de Unión a CREB / Leucemia-Linfoma Linfoblástico de Células Precursoras / Dasatinib / Antineoplásicos Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Año: 2018 Tipo del documento: Article